Bloomberg made the announcement this week, saying that the new facility would jumpstart the city's commercial bioscience
sector by attracting the world's leading healthcare and pharmaceutical companies, and providing needed expansion space for the ity's existing companies.
Scheduled to debut on Ovid Online in January, BioScience
and the Annals will join a list of prestigious basic science titles -- including Science and Nature -- that are already available electronically via the Journals@Ovid online full text database.
In a companion report, "Growing the Nation's Bioscience
Sector: State Bioscience
Initiatives 2006," which was released last year by Battelle and BIO, Indiana was identified as one of the nation's top four life sciences leaders as defined by number and concentration of life sciences-related jobs.
is focused on the development of biotherapeutics through innovative technology.
Omeris is a non-profit bioscience
membership and development organization supported by the Thomas Edison Program of the Ohio Department of Development.
RBM), the leading multiplexed biomarker testing laboratory for the life sciences industry, announced today that it has merged with Lake Placid, New York-based Multiplex Biosciences
The BioOhio agenda also will feature speakers with insight into the availability of both bioscience
jobs and qualified candidates in Ohio.
Cenix and the Cenix BioScience
logo are registered trademarks of Cenix BioScience
2 billion were invested in 94 companies across Ohio to accelerate Ohio's bioscience
growth in 2005, a jump of more than $200 million since 2004.
(OTCBB:PURE) develops and markets technology-based bioscience
products that provide non-toxic solutions to numerous global health challenges.
The rising number of pharmaceutical and biotechnology companies working within drug discovery and the strong emphasis on outsourcing increases MD Biosciences
Corporation (NASDAQ:BRKR) plans to release its fourth quarter and full year 2006 financial results on Thursday, February 22nd, 2007 before the market opens.
, a member of the Sigma-Aldrich Group (NASDAQ: SIAL), and Vivalis, have announced the successful completion of the first stage of their on-going collaboration with the launch of their EX-CELL(TM) EBx(TM) platform, which includes EX-CELL(TM) EBx(TM) viral growth and production media.
Senior Director (Biodiscovery) of EMD Biosciences
is announcing the availability of EdgeWater's updated research report solely for convenience.